首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1909014

胚胎著床前基因檢測市場規模、佔有率和成長分析（按檢測類型、技術、類別、最終用戶和地區分類）—2026-2033年產業預測

Preimplantation Genetic Testing Market Size, Share, and Growth Analysis, By Test Type, By Technology, By Category, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2026年01月01日 | 出版商:

SkyQuest | 英文 185 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球胚胎著床前基因檢測市場規模預計到 2024 年將達到 9.4331 億美元，從 2025 年的 10.1406 億美元成長到 2033 年的 18.0856 億美元，在預測期（2026-2033 年）內複合年成長率為 7.5%。

全球胚胎著床前遺傳學檢測市場正經歷顯著成長，其主要促進因素包括遺傳疾病和不孕症發病率的上升、基因篩檢技術的進步以及體外受精（IVF）基礎設施的完善。遺傳和染色體異常的日益普遍，以及久坐不動的生活方式和環境因素導致的不孕症發病率上升，都推動了對IVF及相關檢測的需求。胚胎著床前遺傳學檢測對於減少IVF週期數、提高成功率至關重要。公眾對遺傳疾病、流產風險和孕產婦健康的日益關注，以及政府支持生殖健康的舉措，進一步推動了市場擴張。然而，高昂的檢測成本、倫理困境、熟練專業人員短缺以及臨床結果的不確定性等挑戰，可能會阻礙未來的市場滲透。

全球胚胎著床前基因檢測市場促進因素

全球試管嬰兒中心、生育診所和專業診斷檢查室數量的不斷成長，推動了對這些服務的需求，並顯著促進了全球胚胎胚胎著床前遺傳學檢測市場的發展。此外，尤其是在新興經濟體，對生殖健康基礎設施的大量投資也為胚胎胚胎著床前遺傳學檢測服務提供者創造了新的機會。為滿足日益成長的對先進生殖技術和基因篩檢方法的需求，以改善患者預後和提高懷孕成功率，全球生育服務基礎設施的擴張在塑造市場積極前景方面發揮關鍵作用。

限制全球胚胎著床前基因檢測市場的因素

由於這些先進技術成本高昂，全球胚胎著床前遺傳學檢測市場面臨嚴峻挑戰。這些費用顯著增加了體外受精（IVF）的整體成本。沉重的經濟負擔可能會阻礙經濟條件有限的夫妻選擇這項治療方案。導致成本增加的因素包括這些檢測所需的複雜技術、必要的實驗室基礎設施和專業知識。此外，缺乏保險覆蓋也加劇了這個問題，使得中低收入者難以獲得胚胎胚胎著床前遺傳學檢測，進一步限制了其普及性和可及性。

全球胚胎著床前基因檢測市場趨勢

全球胚胎著床前遺傳學檢測市場正經歷著向非侵入性遺傳學檢測方法的重大轉變，這主要得益於人們對微創手術日益成長的偏好。利用廢棄胚胎培養基進行無細胞DNA分析的創新技術正在不斷發展，使得無需直接採集胚胎細胞即可進行全面的遺傳學檢測。這項進步不僅最大限度地減少了對胚胎的潛在損傷，還提高了安全性和有效性，使非侵入性技術成為準父母的首選。隨著人們對這些優勢的認知不斷加深，對更安全的遺傳學檢測方法的需求預計將塑造未來市場格局。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Illumina Inc.
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
CooperSurgical Inc.
Abbott Laboratories
Natera Inc.
Genea Limited
Roche Holding AG
Agilent Technologies Inc.
Labcorp Holdings Inc.
Invitae Corp.
Oxford Gene Technology IP
Yikon Genomics
Bioarray SL
Genesis Genetics
Fulgent Genetics
Igenomix
Vitrolife AB
MedGenome Labs
CombiMatrix Corporation

結論與建議

簡介目錄

Product Code: SQMIG35D2364

Global Preimplantation Genetic Testing Market size was valued at USD 943.31 Million in 2024 and is poised to grow from USD 1014.06 Million in 2025 to USD 1808.56 Million by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The global market for preimplantation genetic testing is experiencing significant growth driven by an increase in genetic disorders and infertility rates, coupled with advancements in genetic screening technology and enhanced IVF infrastructure. The prevalence of genetic and chromosomal abnormalities, alongside rising infertility stemming from sedentary habits and environmental factors, fuels the demand for IVF and associated testing. Preimplantation genetic testing is vital in minimizing IVF cycle numbers while boosting success rates. Growing public awareness about genetic conditions, miscarriage risks, and maternal health, along with government initiatives supporting reproductive health, further bolster market expansion. However, challenges like high procedure costs, ethical dilemmas, a shortage of skilled professionals, and uncertainties surrounding clinical outcomes may hinder market penetration moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preimplantation Genetic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Preimplantation Genetic Testing Market Segments Analysis

Global Preimplantation Genetic Testing Market is segmented by Test Type, Technology, Category, End-User and region. Based on Test Type, the market is segmented into Preimplantation Genetic Diagnosis (PGD), Preimplantation Genetic Screening (PGS) / Aneuploidy Screening, HLA Typing / Embryo Matching and Others. Based on Technology, the market is segmented into Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Comparative Genomic Hybridization / Microarray and Single-Nucleotide Polymorphism (SNP) & AI-based Platforms. Based on Category, the market is segmented into Reagents & Consumables, Instruments / Platforms and Software & Bioinformatics Services. Based on End-User, the market is segmented into Fertility Clinics / IVF Centres, Hospitals & Assisted Reproductive Technology (ART) Centres and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Preimplantation Genetic Testing Market

The global preimplantation genetic testing market is being significantly driven by the growing number of IVF centers, fertility clinics, and specialized diagnostic laboratories worldwide, which are enhancing the demand for these services. Additionally, substantial investments in reproductive healthcare infrastructure, particularly in emerging economies, are generating fresh opportunities for providers of preimplantation genetic testing. This expansion of fertility service infrastructure on a global scale is playing a crucial role in shaping the positive outlook for the market, as it accommodates the increasing need for advanced reproductive technologies and genetic screening methods aimed at improving patient outcomes and ensuring successful pregnancies.

Restraints in the Global Preimplantation Genetic Testing Market

The Global Preimplantation Genetic Testing market faces significant challenges due to the high costs associated with these advanced procedures, which significantly increase the overall expense of the in vitro fertilization (IVF) process. The substantial financial burden can deter couples with limited financial resources from pursuing this option. Factors contributing to the elevated costs include the sophisticated technology, necessary laboratory infrastructure, and specialized expertise required for these tests. Additionally, the absence of reimbursement options exacerbates the situation, rendering preimplantation genetic testing largely unattainable for individuals in lower- and middle-income regions, further limiting its adoption and accessibility.

Market Trends of the Global Preimplantation Genetic Testing Market

The Global Preimplantation Genetic Testing market is witnessing a significant shift toward non-invasive genetic testing approaches, propelled by an increasing preference for minimally invasive procedures. Innovations in the analysis of cell-free DNA from spent embryo culture media are gaining traction, allowing for comprehensive genetic testing without the need for direct embryo cell extraction. This advancement not only minimizes potential damage to embryos but also enhances safety and efficiency, positioning non-invasive techniques as a favorable option for prospective parents. As awareness of these benefits spreads, the demand for safer genetic testing methods is expected to shape the future landscape of the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Assessment
Regulatory Landscape

Global Preimplantation Genetic Testing Market Size by Test Type & CAGR (2026-2033)

Market Overview
Preimplantation Genetic Diagnosis (PGD)
Preimplantation Genetic Screening (PGS) / Aneuploidy Screening
HLA Typing / Embryo Matching
Others

Global Preimplantation Genetic Testing Market Size by Technology & CAGR (2026-2033)

Market Overview
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Fluorescence In-Situ Hybridization (FISH)
Comparative Genomic Hybridization / Microarray
Single-Nucleotide Polymorphism (SNP) & AI-based Platforms

Global Preimplantation Genetic Testing Market Size by Category & CAGR (2026-2033)

Market Overview
Reagents & Consumables
Instruments / Platforms
Software & Bioinformatics Services

Global Preimplantation Genetic Testing Market Size by End-User & CAGR (2026-2033)

Market Overview
Fertility Clinics / IVF Centres
Hospitals & Assisted Reproductive Technology (ART) Centres
Diagnostic Laboratories

Global Preimplantation Genetic Testing Market Size & CAGR (2026-2033)

North America (Test Type, Technology, Category, End-User)
- US
- Canada
Europe (Test Type, Technology, Category, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Technology, Category, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Technology, Category, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Technology, Category, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Illumina Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natera Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genea Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labcorp Holdings Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invitae Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Gene Technology IP
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Yikon Genomics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioarray S.L.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genesis Genetics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fulgent Genetics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Igenomix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitrolife AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MedGenome Labs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CombiMatrix Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments